FB Bancorp, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by FB Bancorp, Inc. (the "Company") and its subsidiary, Fidelity Bank (the "Bank"), on April 29, 2026. The report details a governance transition involving Katherine A. Crosby, the Executive Chair of both the Bank and the Company.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and governance changes.
Material Changes
The primary material change is the execution of a Board Chair Realignment and Transition Agreement with Katherine A. Crosby. Key terms include:
- Role Transition: Ms. Crosby will serve as Executive Chair until June 30, 2026 (the "Transition Date"), after which she will become a non-executive Chair and cease her employment position.
- Compensation Continuity: She will receive her current base salary and employee benefits until the Transition Date.
- Health Benefits: The Bank will reimburse COBRA health care costs for Ms. Crosby and her dependents through the COBRA period, capped at the date she attains age 65.
- Restrictive Covenants: Post-employment restrictive covenants from her 2024 Employment Agreement will remain in effect for six months following the Transition Date.
Guidance, Outlook, and Unusual Items
The filing contains no forward-looking guidance, outlook, or management commentary regarding financial performance. The unusual item is the specific severance and retention package granted to Ms. Crosby:
- Cash Payment: A total of $250,000 to be paid in four equal installments of $62,500 on December 31, 2026, June 30, 2027, December 31, 2027, and June 30, 2028.
- Restricted Stock: A grant of restricted stock valued at $250,000 (based on the closing price on the Effective Date), vesting in four approximately equal installments on the same dates as the cash payments.
- Board Fees: Ms. Crosby will continue to receive board fees and participate in the Director Retirement Plan in her capacity as Chair.
Investor Verification Checklist
- Verify the exact vesting schedule and valuation date for the $250,000 restricted stock grant.
- Confirm the specific terms of the post-employment restrictive covenants referenced in Section 12 of the 2024 Employment Agreement.
- Review the Board composition to identify the successor Executive Chair or interim leadership arrangements post-June 30, 2026.
- Assess the impact of the $250,000 cash and stock payments on the Company's near-term compensation expense.